The (pro)renin receptor in health and disease
Abstract
The (pro)renin receptor ((P)RR) was first identified as a single-transmembrane receptor in human kidneys and initially attracted attention owing to its potential role as a regulator of the tissue renin-angiotensin system (RAS). Subsequent studies found that the (P)RR is widely distributed in organs throughout the body, including the kidneys, heart, brain, eyes, placenta and the immune system, and has multifaceted functions in vivo. The (P)RR has roles in various physiological processes, such as the cell cycle, autophagy, acid-base balance, energy metabolism, embryonic development, T cell homeostasis, water balance, blood pressure regulation, cardiac remodelling and maintenance of podocyte structure. These roles of the (P)RR are mediated by its effects on important biological systems and pathways including the tissue RAS, vacuolar H+-ATPase, Wnt, partitioning defective homologue (Par) and tyrosine phosphorylation. In addition, the (P)RR has been reported to contribute to the pathogenesis of diseases such as fibrosis, hypertension, pre-eclampsia, diabetic microangiopathy, acute kidney injury, cardiovascular disease, cancer and obesity. Current evidence suggests that the (P)RR has key roles in the normal development and maintenance of vital organs and that dysfunction of the (P)RR is associated with diseases that are characterized by a disruption of the homeostasis of physiological functions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reactions mediated by angiotensin-converting enzymes play a critical role in regulation of blood pressure, inflammation, vascular permeation, coagulation, and fibrosis.
“These reactions mediated by angiotensin-converting enzymes (ACE-I and ACE-II) play a critical role in the regulation of blood pressure, inflammation, vascular permeation, coagulation, and fibrosis [105].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [105]
The citation lists haven’t been fetched yet
References 272 · Cited by 137
- Authors
- Ichihara, A., & Yatabe, M. S.
- Affiliations
- Tokyo Women's Medical University (JP)
- Corresponding author
- Ichihara, Atsuhiro
- Venue
- Nature Reviews Nephrology
- Published
- 2019-06-04
- Volume
- 15
- Issue
- 11
- Pages
- 693-712
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2948373831
- Cited by
- 137
- References
- 272
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 26 · 2023: 17 · 2022: 11 · 2021: 35 · 2020: 20 · 2019: 1
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- prorenin receptor, renin-angiotensin system, blood pressure regulation, autophagy, energy metabolism, acid-base balance, vacuolar H+-ATPase, Wnt signaling, PAR proteins, tyrosine phosphorylation, fibrosis, chronic kidney disease, preeclampsia, diabetic microangiopathy, acute kidney injury, cardiovascular disease, cancer, obesity, podocytes, cardiac remodeling
- MeSH terms
- Prorenin Receptor, Brain, Eye, Female, Heart, Homeostasis, Humans, Immune System, Kidney, Ocular Physiological Phenomena, Placenta, Pregnancy, Receptors, Cell Surface, Renin-Angiotensin System, Vacuolar Proton-Translocating ATPases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review